Switch to
More onapp

How to use scorecard? Learn more

Coral Laboratories Ltd

CORALAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹312 cr, stock is ranked 2,142
High RiskStock is 4.03x as volatile as Nifty
939.0063.00 (+7.19%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹312 cr, stock is ranked 2,142
High RiskStock is 4.03x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
13.74
PB RatioPB Ratio
1.76
Dividend YieldDiv. Yield
Sector PESector PE
52.29
Sector PBSector PB
6.68
Sector Div YldSctr Div Yld
0.47%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The Company is engaged in the pharmaceutical business. The Company offers products in various categories like sterile, non sterile, nutraceutical and otc products catering to lifestyle segment.

Financial TrendFinancial statements 

2021202220232024100.3681.3885.0590.2913.579.046.4315.78
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnOct 10, 2024

CORAL LABORATORIES LTD. - 524506 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

CORAL LABORATORIES LTD. - 524506 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

AGM/EGM 
Announced OnSep 28, 2024

CORAL LABORATORIES LTD. - 524506 - Submission Of Annual Report For The Financial Year 2023-24 As Duly Approved By The Members Of The Company | Download

CORAL LABORATORIES LTD. - 524506 - Submission Of Annual Report For The Financial Year 2023-24 As Duly Approved By The Members Of The Company | Download

Cash Dividend 
Ex. DateSep 20, 2024

Final • Div/Share: ₹ 2

See all events